Testosterone, thrombophilia, and thrombosis

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 1, 2014, Pages 22-30

  Glueck, Charles J ^a   Richardson Royer, Caitlin ^a   Schultz, Reiker ^a   Burger, Tim ^a   Labitue, Fanta ^a   Riaz, Muhammad K ^a   Padda, Jagjit ^a   Bowe, Dedrick ^a   Goldenberg, Naila ^a   Wang, Ping ^a  

^a JEWISH HOSPITAL   (United States)

Author keywords

anticoagulants; blood coagulation factors; clinical thrombophilia; deep venous thrombosis; endocrinology; hypercoagulability; testosterone

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; ESTRADIOL; HOMOCYSTEINE; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; NANDROLONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TESTOSTERONE; WARFARIN;

ADULT; AFRICAN AMERICAN; AGED; ANDROGEN THERAPY; ARTICLE; BONE NECROSIS; CAUCASIAN; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; HETEROZYGOTE; HIP KNEE OSTEONECROSIS; HOMOZYGOSITY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; THROMBOPHILIA; THROMBOSIS;

ANTICOAGULANTS; BLOOD COAGULATION FACTORS; CLINICAL THROMBOPHILIA; DEEP VENOUS THROMBOSIS; ENDOCRINOLOGY; HYPERCOAGULABILITY; TESTOSTERONE;

ADULT; AGED; BLOOD COAGULATION FACTORS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEONECROSIS; PULMONARY EMBOLISM; TESTOSTERONE; THROMBOPHILIA; THROMBOSIS;

EID: 84880342458     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029613485154     Document Type: Article

References (48)

1. Glueck CJ, Goldenberg N, Budhani S, et al. Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia. Transl Res. 2011 ; 158 (4). 225-234
2. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male. 2002 ; 5 (2). 98-102
3. Cherrier MM, Matsumoto AM, Amory JK, et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005 ; 64 (2). 290-296
4. Jankowska EA, Rozentryt P, Ponikowska B, et al. Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA. 2009 ; 301 (18). 1892-1901
5. Spratt DI, Morton JR, Kramer RS, Mayo SW, Longcope C, Vary CP. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am J Physiol Endocrinol Metab. 2006 ; 291 (3). E631 - E638
6. Abbott RD, Launer LJ, Rodriguez BL, et al. Serum estradiol and risk of stroke in elderly men. Neurology. 2007 ; 68 (8). 563-568
7. Hedlund PO, Gustafson H, Sjogren S.. Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients. Scand J Urol Nephrol Suppl. 1980 ; 55: 103-105
8. Toorians AW, Thomassen MC, Zweegman S, et al. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab. 2003 ; 88 (12). 5723-5729
9. Glueck CJ, Freiberg RA, Wang P. Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head. Clin Orthop Relat Res. 2008 ; 466 (5). 1034-1040
10. Balasa VV, Gruppo RA, Glueck CJ, et al. Legg-Calve-Perthes disease and thrombophilia. J Bone Joint Surg Am. 2004 ; 86-A (12). 2642-2647
11. Glueck CJ, Freiberg RA, Boriel G, et al. The role of the factor V Leiden mutation in Osteonecrosis of the hip. [published online June 12, 2012]. Clin Appl Thromb Hemost. 2012 ;:
12. Svartberg J, Braekkan SK, Laughlin GA, Hansen JB. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study. Eur J Endocrinol. 2009 ; 160 (5). 833-838
13. Balasa VV, Gruppo RA, Glueck CJ, et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost. 1999 ; 81 (5). 739-744
14. Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin Appl Thromb Hemost. 2005 ; 11 (4). 375-389
15. Glueck CJ, Pranikoff J, Aregawi D, et al. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage. Metabolism. 2005 ; 54 (10). 1345-1349
16. Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism. 1993 ; 42 (2). 236-246
17. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res. 2001 ; 386: 19-33
18. GmbH RD. 2010: 1-5.
19. LabCorp Manual ; 2011: 1-3.
20. Vlahos I, MacMahon W, Sgoutas D, Bowers W, Thompson J, Trawick W. An improved ultrafiltration method for determining free testosterone in serum. Clin Chem. 1982 ; 28 (11). 2286-2291
21. Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromato-graphy-tandem mass spectrometry. J Clin Endocrinol Metab. 2004 ; 89 (2). 534-543
22. Rosendaal FR. Etiology of venous thrombosis: the need for small original studies. J Thromb Haemost. 2012 ; 10 (10). 2189-2190
23. Jenkins PV, Rawley O, Smith OP, O'Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012 ; 157 (6). 653-663
24. Glueck CJ, Pranikoff J, Khan N, et al. High factor XI, recurrent pregnancy loss, enoxaparin. Fertil Steril. 2010 ; 94 (7). 2828-2831
25. Farmer-Boatwright MK, Roubey RA. Venous thrombosis in the antiphospholipid syndrome. Arterioscler Thromb Vasc Biol. 2009 ; 29 (3). 321-325
26. Rossi E, Ciminello A, Za T, Betti S, Leone G, De Stefano V.. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband. Thromb Haemost. 2011 ; 106 (4). 646-654
27. Erkekol FO, Ulu A, Numanoglu N, Akar N. High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism. Respirology. 2006 ; 11 (1). 70-74
28. Wong CL, Szydlo R, Gibbs S, Laffan M. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis. 2010 ; 21 (3). 201-206
29. Kyrle PA, Eichinger S. The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism. Wien Klin Wochenschr. 2003 ; 115 (13-14). 471-474
30. Glueck CJ, Freiberg RA, Boppana S, Wang P. Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis. J Bone Joint Surg Am. 2008 ; 90 (10). 2220-2229
31. Glueck CJ, Ping W, Hutchins R, Petersen MR, Golnik K. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions. Clin Appl Thromb Hemost. 2008 ; 14 (3). 286-294
32. Kang J, Ham BK, Oh MM, Kim JJ, Moon du G. Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome. Korean J Urol. 2011 ; 52 (6). 416-420
33. Wang C, Cunningham G, Dobs A, et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 2004 ; 89 (5). 2085-2098
34. Swerdloff RS, Wang C, Cunningham G, et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab. 2000 ; 85 (12). 4500-4510
35. Lakshman KM, Kaplan B, Travison TG, et al. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab. 2010 ; 95 (8). 3955-3964
36. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 1997 ; 277 (16). 1305-1307
37. Middeldorp S. Is thrombophilia testing useful?. Hematology Am Soc Hematol Educ Program. 2011 ; 2011: 150-155
38. Roldan V, Lecumberri R, Munoz-Torrero JF, et al. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res. 2009 ; 124 (2). 174-177
39. Kvasnicka J, Hajkova J, Bobcikova P, et al. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)]. Cas Lek Cesk. 2012 ; 151 (2). 76-82
40. Kaplowitz P. Pubertal development in girls: secular trends. Curr Opin Obstet Gynecol. 2006 ; 18 (5). 487-491
41. Sahraian MA, Mottamedi M, Azimi AR, Moghimi B. Androgen-induced cerebral venous sinus thrombosis in a young body builder: case report. BMC Neurol. 2004 ; 4 (1). 22
42. Schover LR. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?. Fertil Steril. 2008 ; 90 (1). 129-140
43. Signorelli SS, Fiore V, Puccia G, Mastrosimone G, Anzaldi M. Thrombophilia in Patients With Lower Limbs Deep Veins Thrombosis (LDVT) Results of a Monocentric Survey on 103 Consecutive Outpatients. [published online January 29,2013]. Clin Appl Thromb Hemost. 2013 ;:
44. Amiaz R, Pope HG, Mahne T, et al. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther. 2011 ; 37 (4). 243-254
45. Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011 ; 8 (11). 3204-3213
46. Marberger M, Wilson TH, Rittmaster RS. Low serum testosterone levels are poor predictors of sexual dysfunction. BJU Int. 2011 ; 108 (2). 256-262
47. Franchimont P, Kicovic PM, Mattei A, Roulier R. Effects of oral testosterone undecanoate in hypogonadal male patients. Clin Endocrinol (Oxf). 1978 ; 9 (4). 313-320
48. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010 ; 363 (2). 109-122